1st Quarter - Report

CENCORA, INC. for CENCORA, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$420,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 21, 2014 $420,000 Replaced
1st Quarter - Amendment Jan 6, 2016 $420,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Repeal of LIFO (last in, first out).

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
RITA E NORTON —
ANNE OSWALT —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care.H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
RITA E NORTON —
ANNE OSWALT —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1416 (113th), S. 806 (113th), H.R. 800 (113th)

Pharmacy PHA

H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. S. 1277, S. 1657, H.R. 3392 & H.R. 4096 legislation to prevent and reduce prescription drug abuse.H.R. 4190, Provide for coverage under Medicare program of pharmicist services

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
RITA E NORTON —
ANNE OSWALT —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 800 (113th), H.R. 4190 (113th), S. 1657 (113th), H.R. 3392 (113th), S. 806 (113th), S. 1277 (113th), H.R. 1416 (113th), H.R. 4096 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.